Business
Successful launch of products at Supply Side West
Successful launch of products at Supply Side West.

About this update from Optibiotix Health Plc
[{"type":"text","content":"\n \nRNS Number : 6065S OptiBiotix Health PLC 04 October 2017 \n\nOptiBiotix Health plc\n(\"OptiBiotix\" or the \"Company\")\n \nSuccessful launch of LPLDL® and SlimBiome® products at Supply Side West 2017\n \nOptiBiotix Health plc (AIM:OPTI), a life sciences business developing compounds to tackle obesity,high cholesterol, and diabetes announces the successful launch of its SlimBiome® and LPLDL® products at Supply Side West in Las Vegas, on 27-28 September 2017. The exhibition provided the opportunity to connect with 16,500 ingredient buyers and suppliers from the supplement, beverage, functional food, personal care and sports nutrition industries. The event also created the opportunity to meet with senior executives from existing corporate partners and potential new corporate partners, as well as distributors from Europe, the USA and Asia. \n \nThe Company recently obtained FDA registration for both its LPLDL® and SlimBiome® product ranges allowing it to present its products at Supply Side West as the first of a number of commercial steps to supply these functional ingredients to food, beverage, consumer healthcare and pharmaceutical partners for distribution and sale into the US market. LPLDL® was co-exhibited with Sacco, one of the largest suppliers of probiotic ingredients, whilst SlimBiome® was co-exhibited with specialty ingredients manufacturer, Cereal Ingredients. \n \nBoth LPLDL® and SlimBiome® were extremely well received with high interest in the distribution and sale of these products from partners across Europe, Japan, India, Asia and the USA. Further updates will be provided as interest develops into commercial agreements but early outcomes from the exhibition include:-\n \n1. Sacco have appointed Dr Lucio Lepera as Product Manager for LPLDL®. This is a significant financial commitment from Sacco, to support entry to the US probiotic market and extend the opportunities offered by LPLDL® into dairy applications to access the $35.5 billion probiotic dairy market.\n \n2. Cereal Ingredients have incorporated SlimBiome® into their range of cereal based particulates and speciality ingredients. This technical innovation extends the application of SlimBiome® into bakery products (e.g. cookies, cakes a...